NCT05664308 Interest of a Hybrid Connected Watch for Cardiac Rhythm Monitoring in Post-operative Cardiac Surgery
| NCT ID | NCT05664308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 106 participants |
| Start Date | 2024-03-19 |
| Primary Completion | 2026-03-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 106 participants in total. It began in 2024-03-19 with a primary completion date of 2026-03-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this single-center pilot study is, with the help of a connected watch, to show the absence of recurrence or maintenance of sinus rhythm in patients with a Post Operative Atrial Fibrillation (POAF) and to help treating cardiologists in the care of these patients.
Eligibility Criteria
Inclusion Criteria: * Major with an indication for conventional cardiac surgery with de novo postoperative AF onset. * Agreeing to participate in the study and having signed an informed consent. * Agreeing to undergo 12 months of postoperative monitoring. Exclusion Criteria: * Patient with pre-operative AF * Patient who does not have a smartphone compatible with the connected watch. * Patient unable to perform an ECG measurement independently. * Patient with a physical constraint to the measurement (arteriovenous fistula...) * Minors * Pregnant or breast-feeding women * Adults under guardianship, under curatorship * Patients whose life expectancy is less than 1 year * Patients participating in another therapeutic trial likely to impact the evaluation criteria of the MONHYCARD study * Contraindication to long-term anticoagulants * Patients implanted with a mechanical valve prosthesis pre-operatively or after surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05664308 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05664308 currently recruiting?
Yes, NCT05664308 is actively recruiting participants. Contact the research team at charleshenri.david@chu-nantes.fr for enrollment information.
Where is the NCT05664308 trial being conducted?
This trial is being conducted at Nantes, France.
Who is sponsoring the NCT05664308 clinical trial?
NCT05664308 is sponsored by Nantes University Hospital. The trial plans to enroll 106 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.